Cuba says second COVID-19 vaccine Soberana 2 boasts 91.2% efficacy
By REUTERS
Cuba said on Thursday its two-shot Soberana 2 vaccine, delivered with a booster called Soberana Plus, had proven 91.2% effective in late stage clinical trials against the coronavirus, following similar news about its Abdala vaccine.
Uncrewed aerial system launched from Yemen's Houthi area
